Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


‘We Want You To Stay,’ EU Agency Heads Tell UK

Executive Summary

The role of the UK drug regulator in the EU post-Brexit will depend on the outcome of complex negotiations. It’s clear that the loss of the MHRA from the network would be keenly felt by other agencies across Europe.


Related Content

UK Life Science Industry Presses Government On Need For Continued Regulatory Alignment Post-Brexit
UK Regulator Has Key Role in One in Four EU-Wide Approvals
Spanner In Works For UK Gov’t’s Brexit Plans; Industry Looks To Ongoing Talks With Ministers





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts